Brazil’s in Vitro Diagnostic Market Growing Faster Than the Overall IVD Market
The Brazilian market represents a significant opportunity for IVD diagnostic companies. This report includes market size for the Brazilian IVD market, products, Brazil market trends, and company profiles.
Rockville, MD, August 29, 2010 --(PR.com)-- MarketResearch.com has announced the addition of Kalorama Information’s new report “McEvoy and Farmer's Complete Guide to IVD Distribution in Brazil” to their collection of reports. For more information, visit:
http://www.marketresearch.com/product/display.asp?productid=2765003
Brazil’s in vitro diagnostic market nearly doubled since 2003 and is growing at a faster than average rate compared to the IVD market worldwide, according to healthcare market research publisher Kalorama Information. With a population of 191 million, Brazil is by far the largest country in South America. There is a continuing trend towards urbanization, with most Brazilians now living in cities. According to a new report from Kalorama about the Brazilian diagnostics market, a growing economy and multi-billion dollar spending on healthcare have brought most of the significant IVD companies to the region.
“Brazil is the target of choice in Latin America,” says Bruce Carlson, publisher of Kalorama Information. “It’s a combination of three important factors: a large population makes it worth the resource commitment, the country survived the recession and healthcare spending is strong.”
According to Kalorama Information, Brazil spent US $126 billion on healthcare in 2009. Healthcare is provided at no charge to all of Brazil’s citizens at public hospitals; employees and employers contribute to the National Institute for Social Security (INPS) to pay for this service. Additionally, public resources for healthcare come from federal, state and municipal government budgets, as well as some foundations; specifically, the federal government funds 65% of public healthcare spending, while municipal and local sources fund the rest. Total spending on healthcare is roughly 8% of GDP.
Abbott, Bio-Rad, Siemens and Becton Dickinson are among the big players in Brazil, according to the report.
More information can be found in the report, “McEvoy and Farmer’s Complete Guide to IVD Distribution in Brazil,” a joint publication of Kalorama Information and McEvoy and Farmer, a market research firm covering emerging IVD markets. The report provides forecasts for various IVD segments and lists distributors, as well as their clients.
For more information, visit:
http://www.marketresearch.com/product/display.asp?productid=2765003
Contact:
Veronica Franco
MarketResearch.com
vfranco@marketresearch.com
240.747.3016
###
http://www.marketresearch.com/product/display.asp?productid=2765003
Brazil’s in vitro diagnostic market nearly doubled since 2003 and is growing at a faster than average rate compared to the IVD market worldwide, according to healthcare market research publisher Kalorama Information. With a population of 191 million, Brazil is by far the largest country in South America. There is a continuing trend towards urbanization, with most Brazilians now living in cities. According to a new report from Kalorama about the Brazilian diagnostics market, a growing economy and multi-billion dollar spending on healthcare have brought most of the significant IVD companies to the region.
“Brazil is the target of choice in Latin America,” says Bruce Carlson, publisher of Kalorama Information. “It’s a combination of three important factors: a large population makes it worth the resource commitment, the country survived the recession and healthcare spending is strong.”
According to Kalorama Information, Brazil spent US $126 billion on healthcare in 2009. Healthcare is provided at no charge to all of Brazil’s citizens at public hospitals; employees and employers contribute to the National Institute for Social Security (INPS) to pay for this service. Additionally, public resources for healthcare come from federal, state and municipal government budgets, as well as some foundations; specifically, the federal government funds 65% of public healthcare spending, while municipal and local sources fund the rest. Total spending on healthcare is roughly 8% of GDP.
Abbott, Bio-Rad, Siemens and Becton Dickinson are among the big players in Brazil, according to the report.
More information can be found in the report, “McEvoy and Farmer’s Complete Guide to IVD Distribution in Brazil,” a joint publication of Kalorama Information and McEvoy and Farmer, a market research firm covering emerging IVD markets. The report provides forecasts for various IVD segments and lists distributors, as well as their clients.
For more information, visit:
http://www.marketresearch.com/product/display.asp?productid=2765003
Contact:
Veronica Franco
MarketResearch.com
vfranco@marketresearch.com
240.747.3016
###
Contact
MarketResearch.com
Veronica Franco
240.747.3016
www.marketresearch.com/
Veronica Franco
240.747.3016
www.marketresearch.com/
Contact
Categories